# Rapamycin With Grapefruit Juice for Advanced Malignancies

> **NCT00375245** · PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 41 (actual)

## Conditions studied

- Tumors
- Neoplasm Metastasis

## Interventions

- **DRUG:** Rapamycin (sirolimus)
- **OTHER:** Grapefruit Juice

## Key facts

- **NCT ID:** NCT00375245
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-05
- **Final completion:** 2012-05
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375245, "Rapamycin With Grapefruit Juice for Advanced Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00375245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*